Pluri Secures $3.0M via Registered Direct Offering Priced at $1.50 with Warrants
PLUR is trading near its 52-week low of $1.45 (3.4% above the low) on elevated volume (3.5× avg).
Summary
Pluri Inc. raised approximately $3.0 million through a registered direct offering of 1.2 million shares and pre-funded warrants, with additional warrants in a concurrent private placement. The deal provides critical working capital but adds significant potential dilution at a price near the 52-week low.
Key Events · Financing and Capital Events · PLUR
-
Registered Direct Offering of $3.0M
Pluri is selling 1,200,000 common shares at $1.50 per share, raising approximately $3.0 million in net proceeds after placement agent fees and expenses.
-
Pre-Funded Warrants for 1.03M Shares
The offering includes pre-funded warrants to purchase up to 1,028,940 common shares at $0.00001 per share, exercisable immediately with no expiration date.
-
Concurrent Private Placement Warrants
A concurrent private placement issues warrants to purchase up to 2,228,940 common shares at $1.65 per share, exercisable after six months and expiring in 5.5 years.
-
Going Concern and Nasdaq Delisting Risk
The company has less than three months of cash runway, a $27.4 million EIB loan maturity, and a Nasdaq delisting notice for failing the $35 million market value requirement.
Analysis · PLUR · Life Sciences
Pluri Inc. is selling 1.2 million common shares plus pre-funded warrants for up to 1.03 million additional shares at a combined price of $1.50 per unit, raising approximately $3.0 million in net proceeds. The deal also includes a concurrent private placement of warrants to purchase up to 2.23 million shares at $1.65 per share. This capital injection is critical for a company with less than three months of cash runway and a $27.4 million EIB loan maturity looming, but it comes at a steep cost: the offering price is near the 52-week low of $1.45, and the warrant overhang could add up to 3.26 million shares if fully exercised. The company is fighting a Nasdaq delisting notice and has already slashed its ATM program from $10 million to $290,000, underscoring the urgency of this raise.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.6% of the 1216 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PLUR was trading at $1.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.5M. The 52-week trading range was $1.45 to $5.49. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.